📊 BRKRP Key Takeaways
Is Bruker Corp. (BRKRP) a Good Investment?
Bruker demonstrates solid revenue growth and healthy gross margins (45.9%), but is currently unprofitable with negative net income and concerning operating leverage issues. The company generates positive free cash flow (43.3M) and maintains reasonable liquidity, though weak interest coverage (1.4x) and high debt levels warrant caution on near-term financial flexibility.
Bruker shows acceptable scale and solid gross margins, but the latest period reflects very weak earnings conversion, with only 2.0% operating margin, a small net loss, and thin 1.3% free cash flow margin. Revenue growth of 2.1% is modest, and with interest coverage at just 1.4x, the company needs materially better operating execution for fundamentals to strengthen.
Why Buy Bruker Corp. Stock? BRKRP Key Strengths
- Strong gross margin of 45.9% indicates pricing power and operational efficiency in core business
- Positive free cash flow generation of 43.3M despite net losses shows underlying cash generation ability
- Solid current ratio of 1.73x provides adequate short-term liquidity cushion
- Modest revenue growth of 2.1% YoY in a capital-intensive analytical instruments sector
- Gross margin of 45.9% indicates solid product economics and pricing power at the gross profit level
- Current ratio of 1.73x suggests adequate near-term balance sheet liquidity
- Positive operating cash flow and free cash flow show the business is still generating cash despite weak earnings
BRKRP Stock Risks: Bruker Corp. Investment Risks
- Currently unprofitable with negative net margin (-0.3%) and negative ROE (-0.4%), indicating operational challenges
- Weak interest coverage ratio of 1.4x with 1.9B in long-term debt creates refinancing and financial distress risk
- Operating margin severely compressed at 2.0% despite 45.9% gross margins, suggesting SG&A and operational inefficiencies
- Low quick ratio of 0.87x indicates potential liquidity stress if current liabilities accelerate
- Significant 16 Form 4 insider filings in last 90 days warrant monitoring for insider sentiment
- Operating profitability is very weak, with only 2.0% operating margin and negative net income
- Interest coverage of 1.4x leaves limited cushion against financing pressure
- Growth quality is weak because modest revenue growth is not translating into strong earnings or cash flow expansion
Key Metrics to Watch
- Operating margin improvement trajectory and SG&A expense control
- Net income return to profitability and sustainability of positive FCF
- Debt reduction progress and interest coverage ratio stabilization above 2.0x
- Gross margin sustainability amid potential pricing pressure or product mix shifts
- Operating margin and interest coverage improvement
- Free cash flow margin and operating cash flow conversion
Bruker Corp. (BRKRP) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 1.3% FCF margin may limit capital allocation flexibility.
BRKRP Profit Margin, ROE & Profitability Analysis
BRKRP vs Industrial Sector: How Bruker Corp. Compares
How Bruker Corp. compares to Industrial sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Bruker Corp. Stock Overvalued? BRKRP Valuation Analysis 2026
Based on fundamental analysis, Bruker Corp. shows some fundamental concerns relative to the Industrial sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Bruker Corp. Balance Sheet: BRKRP Debt, Cash & Liquidity
BRKRP Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Bruker Corp.'s revenue has grown significantly by 42% over the 5-year period, indicating strong business expansion. The most recent EPS of $2.90 reflects profitable operations.
BRKRP Revenue Growth, EPS Growth & YoY Performance
BRKRP Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $860.5M | -$34.6M | $-0.25 |
| Q2 2025 | $797.4M | $7.6M | $0.05 |
| Q1 2025 | $721.7M | $17.4M | $0.11 |
| Q3 2024 | $742.8M | $40.9M | $0.27 |
| Q2 2024 | $681.9M | $7.6M | $0.05 |
| Q1 2024 | $685.3M | $50.9M | $0.35 |
| Q3 2023 | $638.9M | $88.1M | $0.59 |
| Q2 2023 | $588.4M | $49.5M | $0.33 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Bruker Corp. Dividends, Buybacks & Capital Allocation
BRKRP SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Bruker Corp. (CIK: 0001109354)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BRKRP
What is the AI rating for BRKRP?
Bruker Corp. (BRKRP) has a Combined AI Rating of SELL from Claude (HOLD) and ChatGPT (SELL) with 68% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BRKRP's key strengths?
Claude: Strong gross margin of 45.9% indicates pricing power and operational efficiency in core business. Positive free cash flow generation of 43.3M despite net losses shows underlying cash generation ability. ChatGPT: Gross margin of 45.9% indicates solid product economics and pricing power at the gross profit level. Current ratio of 1.73x suggests adequate near-term balance sheet liquidity.
What are the risks of investing in BRKRP?
Claude: Currently unprofitable with negative net margin (-0.3%) and negative ROE (-0.4%), indicating operational challenges. Weak interest coverage ratio of 1.4x with 1.9B in long-term debt creates refinancing and financial distress risk. ChatGPT: Operating profitability is very weak, with only 2.0% operating margin and negative net income. Interest coverage of 1.4x leaves limited cushion against financing pressure.
What is BRKRP's revenue and growth?
Bruker Corp. reported revenue of $3.4B.
Does BRKRP pay dividends?
Bruker Corp. pays dividends, with $22.8M distributed to shareholders in the trailing twelve months.
Where can I find BRKRP SEC filings?
Official SEC filings for Bruker Corp. (CIK: 0001109354) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BRKRP's EPS?
Bruker Corp. has a diluted EPS of $-0.15.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BRKRP a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Bruker Corp. has a SELL rating with 68% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BRKRP stock overvalued or undervalued?
Valuation metrics for BRKRP: ROE of -0.4% (sector avg: 15%), net margin of -0.3% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy BRKRP stock in 2026?
Our dual AI analysis gives Bruker Corp. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is BRKRP's free cash flow?
Bruker Corp.'s operating cash flow is $134.1M, with capital expenditures of $90.8M. FCF margin is 1.3%.
How does BRKRP compare to other Industrial stocks?
Vs Industrial sector averages: Net margin -0.3% (avg: 10%), ROE -0.4% (avg: 15%), current ratio 1.73 (avg: 1.8).